The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
From packing your on-the-go bag to prepping your syringe or insulin pen, here are tips to get you started. Insulin may be one option for helping to manage type 2 diabetes. You can also learn more ...
"The skyrocketing list price of insulin has had devastating consequences ... to three vials or two packs of FlexPen/FlexTouch/PenFill pens) for $35 [and] Immediate Supply: a one-time free short ...
MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect adherence to injecting bolus insulin in people living with diabetes ...
1 Over the past 2 decades, pharmaceutical companies raised insulin list prices annually ... lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes ...
Millions of UK residents have received a warning amid concerns about the underreporting of issues with a much used medical ...
Durban — Médecins Sans Frontières (MSF) has voiced its strong condemnation of Novo Nordisk’s recent decision to cease the production of human insulin pens, a move that critically undermines ...
Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...
Texas Attorney General Ken Paxton's office said on Thursday it had sued insulin makers Eli Lilly, Novo Nordisk and Sanofi.
compared to prefilled pens they get at a local pharmacy. But the move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole new set of ...
For instance, if there were six short-acting insulin products on an insurance plan’s approved drug list, the insurer had to offer one vial form and one pen form at $35. These price changes did ...
Delving into the presidential candidates’ successes on a number of drug-pricing policies, you’ll see a continuation of progress across the administrations. Neither the Trump administration nor the ...